Clinical significance of TLR1 I602S polymorphism for patients with metastatic colorectal cancer treated with FOLFIRI plus bevacizumab

Por Okazaki, Satoshi, Loupakis, Fotios, Stintzing, Sebastian, Cao, Shu, Zhang, Wu, Yang, Dongyun, Ning, Yan, Sunakawa, Yu, Stremitzer, Stefan, Matsusaka, Satoshi, Berger, Martin D., Parekh, Anish, West, Jordan D., Miyamoto, Yuji, Suenaga, Mitsukuni, Schirripa, Marta, Cremolini, Chiara, Falcone, Alfredo, Heinemann, Volker, DePaolo, R. William, Lenz, Heinz-Josef
Publicado no Mol Cancer Ther (2016)